|
Market Cap (17-May) $40,671,720 (1,053rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 400,697 |
Shortsold (10-Dec) 1,128,575 (0.62%) (255th) |
|
52w High $0.345 |
52w Low $0.140 |
P/E - |
EPS -0.05 |
CYP released this announcement to the ASX on 21 April 2022, 9:23. The announcement is not marked as price sensitive, and is 1 page(s) in length and 247.03kb in size.
You can view all announcements from CYP and see how they appear on a price chart on the announcements page.
At the date of this announcement, CYP was 0.021% short sold according to ASIC data. It was ranked the 579th most shorted stock on the ASX. It is now ranked as the 255th most shorted stock on the ASX with 0.624% of total shares short sold as of the latest reported data (10 December 2024).
| Other Recent Announcements from CYP | |
|---|---|
| Notification regarding unquoted securities - CYP | 30 June 2023, 13:10 |
| Proposed issue of securities - CYP | 30 June 2023, 9:44 |
| Cynata announces CEO succession and Board changes | 30 June 2023, 9:13 |
| Cynata Advances Clinical Trial in Diabetic Foot Ulcers | 21 April 2022, 9:23 |
| Updated Investor Presentation | 8 March 2022, 9:07 |
| Notice of Allowance for Cynata Chinese Patent | 28 February 2022, 9:30 |
| Appendix 4D & Half-Year Financial Statements | 25 February 2022, 14:59 |
You must be logged in to post a reply.
Cynata Therapeutics 